Recent advances in the management of atypical meningiomas - 17/08/16
pages | 10 |
Iconographies | 5 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Based on the 2007 WHO classification, the proportion of atypical meningiomas has steeply increased. Complete resection is usually considered curative, however, the recurrence rate remains high. The treatment of more aggressive meningiomas remains problematic. We performed a literature review via the PubMed database with specific attention to radiological, pathological, genetic and molecular aspects particular to WHO grade II meningiomas and current therapeutic strategies. We also reviewed the role of surgery and summarized the results of the principal studies dealing with adjuvant strategies based on the most recent evidence. Adjuvant radiotherapy, administered as stereotactic radiosurgery or conventional external beam irradiation, should be strongly considered in selected cases. Limited data exist regarding the role of hormonal treatment or chemotherapy as adjunct therapy. A target therapy modulating the altered molecular balance may be the key to revolutionize the prognosis of these patients.
Le texte complet de cet article est disponible en PDF.Keywords : Atypical meningioma, WHO grade II meningioma, Management, Genetics, Molecular biology, Radiology, Surgery, Adjuvant radiotherapy, Stereotactic radiosurgery, Conventional external beam radiotherapy
Plan
Vol 62 - N° 4
P. 213-222 - août 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?